NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve the Unaudited financial results for the quarter and half year ended 30th September 2024 and 2nd Interim Dividend if any
हाल में देखा गया
सब क्लियर करें